Please login to the form below

Not currently logged in
Email:
Password:

EY

This page shows the latest EY news and features for those working in and with pharma, biotech and healthcare.

Life science companies can’t keep up with technology competitors

Life science companies can’t keep up with technology competitors

Companies in the life science sector are under threat from its technology competitors, according to a new report released by accounting firm EY. ... Pamela Spence, global life sciences industry leader at EY, said: “The rapid emergence of technology

Latest news

  • Taming the Monster Taming the Monster

    Pharma has historically focused on ‘input’measures, ”says Aaron Bean, director and commercial life sciences lead, EY UK &Ireland.

  • Google: We're not a big healthcare company... yet Google: We're not a big healthcare company... yet

    It’s the interview with Schmidt that is particularly pertinent for these pages, not least given a recent EY report, which concludes: “Make no mistake: technology firms, wellness companies and other

  • R&D productivity still a big problem for biopharma R&D productivity still a big problem for biopharma

    But while that level of investment is impressive, the sector needs to drive "efficiency improvements to achieve better returns and ultimately to drive greater affordability of its products", according to ... Make no mistake: technology firms, wellness

  • Fair to medalling Fair to medalling

    Generally competent at strategic planning, how can pharma transition from acceptable to exceptional to deliver gold standard performances?

  • Celebrating excellence Celebrating excellence

    Chair of Judges for PMEA 2015, Daniel Mathews is the UK partner of EY's Life Science Practice. ... This year entries were assessed by a panel of experienced, independent industry judges from the likes of EY, Quintiles, Engage, PA Consulting, Cello Health

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 6 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • EY and P&G Partnership Yields New Systems, Delivery Models

    EY and P&G Partnership Yields New Systems, Delivery Models. Downloads. . ... EY and P&G Partnership Yields New Systems, Delivery Models.

  • EY Life Sciences Sector Update

    EY Life Sciences Sector Update. Asia-Pacific and Japan. Downloads. . ... EY Life Sciences Sector Update - Asia-Pacific and Japan.

  • emotive. launches new graduate program

    During the program, th. ey will work with the medical, creative, technical, quality assurance and client services teams on live client projects, with a view to building a strong foundation and

  • Global Corporate Divestment Study

    Global Corporate Divestment Study. EY's Global Corporate Divestment Study (GDS), focuses on the lessons corporates can learn from private equity firms— from improving portfolio reviews to divestment execution.

  • A roadmap to strategic drug pricing

    A roadmap to strategic drug pricing. The current unit-based pricing model for drugs is too one-dimensional for the market's present needs. Pharma firms must identify products that will benefit from innovative pricing models, and then forge the types

More from PMHub
Approximately 1 fully matching, plus 19 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics